Large-scale RCTs were published in 2021, comparing the effect of treatment and prophylactic doses in patients with moderate and severe COVID-19, which showed no significant difference in mortality or major bleeding between the two groups but a slightly significant decrease in VTE with the treatment dose [ 10 , 11 ].
← all excerpts
Efficacy of different anticoagulant doses for patients with COVID-19: a systematic review and network meta-analysis.
1
—
—